Evidence map›Paper›PMID 24549138›Full record

ArticleInternational journal of obesity (2005)2014

DNA methylation of leptin and adiponectin promoters in children is reduced by the combined presence of obesity and insulin resistance.

M C García-Cardona, F Huang, J M García-Vivas, C López-Camarillo, B E Del Río Navarro, E Navarro Olivos, E Hong-Chong, F Bolaños-Jiménez, L A Marchat

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in International journal of obesity (2005), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 103 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Genetic and Epigenetic Factors in Gestational Diabetes Mellitus Pathology.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Effects of DNA methylation on cardiometabolic risk factors: a systematic review and meta-analysis.Archives of public health = Archives belges de sante publique · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

M C García-CardonaPrograma de Biomedicina Molecular, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, México City, Mexico.
F HuangLaboratorio de Farmacología y Toxicología, Hospital Infantil de México Federico Gómez, México City, Mexico.
J M García-VivasPrograma de Biotecnología, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, México City, Mexico.
C López-CamarilloPosgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, México City, Mexico.
B E Del Río NavarroDepartamento de Alergia, Hospital Infantil de México Federico Gómez, México City, Mexico.
E Navarro OlivosDepartamento de Salud Pública, Instituto Nacional de Salud Pública, Cuernavaca Morelos, México City, Mexico.
E Hong-ChongDepartamento de Farmacología, CINVESTAV-IPN, México City, Mexico.
F Bolaños-JiménezINRA, UMR1280 Physiologie des Adaptations Nutritionnelles, Université de Nantes, Nantes Atlantique Université, Nantes, France.
L A Marchat1] Programa de Biomedicina Molecular, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, México City, Mexico [2] Programa de Biotecnología, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, México City, Mexico.
Instituto Politécnico Nacional · MXHospital Infantil de México Federico Gómez · MXCenter for Research and Advanced Studies of the National Polytechnic Institute · MXInstituto Nacional de Salud Pública · MXPhysioPathologie des Adaptations Nutritionnelles · FRUniversidad Autónoma de la Ciudad de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveEpigenetic alterations have been suggested to be associated with obesity and related metabolic disorders. Here we examined the correlation between obesity and insulin resistance with the methylation frequency of the leptin (LEP) and adiponectin (ADIPOQ) promoters in obese adolescents with the aim to identify epigenetic markers that might be used as tools to predict and follow up the physiological alterations associated with the development of the metabolic syndrome. SUBJECTS: One hundred and six adolescents were recruited and classified according to body mass index and homeostasis model of assessment-insulin resistance index. The circulating concentrations of leptin, adiponectin and of several metabolic markers of obesity and insulin resistance were determined by standard methods. The methylation frequency of the LEP and ADIPOQ promoters was determined by methylation-specific PCR (MS-PCR) in DNA obtained from peripheral blood samples.

resultsObese adolescents without insulin resistance showed higher and lower circulating levels of, respectively, leptin and adiponectin along with increased plasmatic concentrations of insulin and triglycerides. They also exhibited the same methylation frequency than lean subjects of the CpG sites located at -51 and -31 nt relative to the transcription start site of the LEP gene. However, the methylation frequency of these nucleotides dropped markedly in obese adolescents with insulin resistance. We found the same inverse relationship between the combined presence of obesity and insulin resistance and the methylation frequency of the CpG site located at -283 nt relative to the start site of the ADIPOQ promoter.

conclusionsThese observations sustain the hypothesis that epigenetic modifications might underpin the development of obesity and related metabolic disorders. They also validate the use of blood leukocytes and MS-PCR as a reliable and affordable methodology for the identification of epigenetic modifications that could be used as molecular markers to predict and follow up the physiological changes associated with obesity and insulin resistance.

Indexed as

DNA MethylationInsulin ResistanceAdiponectinAdolescentBiomarkersBlood GlucoseBody Mass IndexChildEnzyme-Linked Immunosorbent AssayFemaleGenes, RegulatorHomeostasisHumansLeptinMaleMetabolic SyndromeAdiponectinADIPOQ protein, humanBiomarkersBlood GlucoseLeptin

Identifiers

PMID24549138
OpenAlexW2053308873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.